Man K. Ho, Ph.D.
Affiliations: | 2011 | Pharmacology and Toxicology | University of Toronto, Toronto, ON, Canada |
Area:
Addiction, Drug MetabolismGoogle:
"Man Ho"Mean distance: 17.34 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentor| Rachel F. Tyndale | grad student | 2011 | University of Toronto | |
| (Impact of CYP2A6 genetic variation on nicotine metabolism and smoking behaviours in light smoking populations of Black-African descent.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ho MK, Goldman D, Heinz A, et al. (2010) Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clinical Pharmacology and Therapeutics. 88: 779-91 |
| Ho MK, Faseru B, Choi WS, et al. (2009) Utility and relationships of biomarkers of smoking in African-American light smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 3426-34 |
| Ho MK, Mwenifumbo JC, Al Koudsi N, et al. (2009) Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers. Clinical Pharmacology and Therapeutics. 85: 635-43 |
| Mwenifumbo JC, Al Koudsi N, Ho MK, et al. (2008) Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. Human Mutation. 29: 679-88 |
| Ho MK, Mwenifumbo JC, Zhao B, et al. (2008) A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent. Pharmacogenetics and Genomics. 18: 67-75 |
| Ho MK, Tyndale RF. (2007) Overview of the pharmacogenomics of cigarette smoking. The Pharmacogenomics Journal. 7: 81-98 |